Alto Neuroscience, Inc (NYSE:ANRO) IPO will take place February, 02 on the NYSE exchange under the ticker ANRO.
The company is offering shares at an expected price between $14.00 and $16.00 per share with an insider lock-up period of 180 days ending on July 31, 2024.
See also: Benzinga IPO Calendar
About Alto Neuroscience, Inc
Alto Neuroscience, Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging neurobiology to develop personalized and highly effective treatment options. Building on more than a decade of research by our founder, Dr. Amit Etkin, we aim to deeply understand brain function and match patients to the right medication more efficiently through the use of treatments that, if approved, are tailored to specific patient populations.
See also: Benzinga’s Most Shorted Stocks
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
